Evidence map›Paper›PMID 41601195›Full record

ArticleJournal of sleep research2026

Serum Concentrations of Cytokines in Patients With Restless Legs Syndrome.

Félix Javier Jiménez-Jiménez, Pedro Ayuso, Hortensia Alonso-Navarro, Marisol Calleja, Ignacio Álvarez, Pau Pastor, Santiago Navarro-Muñoz, Laura Turpín-Fenoll, Jorge Millán-Pascual, Esteban García-Albea and 2 more

Abstract read
In one paragraph

Article in Journal of sleep research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Félix Javier Jiménez-JiménezSection of Neurology, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain.ORCID 0000-0002-7558-7323
Pedro AyusoUniversity Institute of Molecular Pathology Biomarkers, ARADyAL Instituto de Salud Carlos III, Universidad de Extremadura, Cáceres, Spain.ORCID 0000-0002-9441-4022
Hortensia Alonso-NavarroSection of Neurology, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain.ORCID 0000-0001-8644-2210
Marisol CallejaSection of Neurology, Hospital Universitario del Sureste, Arganda del Rey, Madrid, Spain.
Ignacio ÁlvarezFundació per la Recerca Biomèdica i Social Mútua de Terrassa, Terrassa, Barcelona, Spain.ORCID 0000-0002-8537-3935
Pau PastorFundació per la Recerca Biomèdica i Social Mútua de Terrassa, Terrassa, Barcelona, Spain.ORCID 0000-0002-7493-8777
Santiago Navarro-MuñozSection of Neurology, Hospital La Mancha-Centro, Alcázar de San Juan, Ciudad Real, Spain.
Laura Turpín-FenollSection of Neurology, Hospital La Mancha-Centro, Alcázar de San Juan, Ciudad Real, Spain.
Jorge Millán-PascualSection of Neurology, Hospital La Mancha-Centro, Alcázar de San Juan, Ciudad Real, Spain.
Esteban García-AlbeaDepartment of Medicine-Neurology, Hospital "Príncipe de Asturias", Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.
José A G AgúndezUniversity Institute of Molecular Pathology Biomarkers, ARADyAL Instituto de Salud Carlos III, Universidad de Extremadura, Cáceres, Spain.ORCID 0000-0001-6895-9160
Elena García-MartínUniversity Institute of Molecular Pathology Biomarkers, ARADyAL Instituto de Salud Carlos III, Universidad de Extremadura, Cáceres, Spain.ORCID 0000-0002-8094-046X

Funding

European Regional Development FundInstituto de Salud Carlos III PI21/01683Instituto de Salud Carlos III PI24/01358
6 · The paper itself

Abstract

Several data suggested a possible role of inflammatory factors in restless legs syndrome (RLS). In this regard, the results of a limited number of studies assessing serum or plasma levels of cytokines have been inconclusive. To investigate the possible role of several cytokines (tumour necrosis factor α-TNF-α, and interleukins-IL-1α, IL-1β, IL-6 and IL-10) as markers of idiopathic RLS (iRLS), we have measured their serum levels in a large series of iRLS patients and controls. We assessed serum levels of TNF-α, IL-1α, IL-1β, IL-6 and IL-10 in 100 patients diagnosed with iRLS and 110 age- and sex-matched healthy controls using a monoclonal Enzyme-Linked ImmunoSorbent Assay (ELISA) method. Serum levels of IL-1α and IL-1β were below detection limits both in iRLS patients and controls. Serum TNF-α, IL-6 and IL-10 levels did not differ significantly between iRLS patients and controls in the whole series, although TNF-α levels were lower in male iRLS patients compared with male iRLS controls. Serum TNF-α, IL-6 and IL-10 levels were not correlated with age at onset and severity of RLS. The data from the current study suggest that serum levels of the cytokines studied cannot be considered useful markers of iRLS.

Indexed as

CytokinesRestless Legs SyndromeAdultAgedBiomarkersCase-Control StudiesEnzyme-Linked Immunosorbent AssayFemaleHumansInterleukin-10Interleukin-1betaInterleukin-6MaleMiddle AgedTumor Necrosis Factor-alphaBiomarkersCytokinesInterleukin-10Interleukin-1betaInterleukin-6Tumor Necrosis Factor-alphacytokinesinflammationrestless legs syndromeserum levels

Identifiers

PMID41601195
PMCPMC13357818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.